The FDA has identified another recall for the Alaris infusion pump from BD (NYSE:BDX) as Class I, the most serious kind of recall.
BD’s latest recall, initiated on March 3, 2021, involves its BD Alaris infusion pump module system, which includes an infusion pump and vital signs monitoring system with a PC unit, the Guardrails Suite MX and up to four removable infusion or monitoring modules (channels), according to an FDA notice.
Get the full story at our sister site, Drug Delivery Business News.
